Technology Assessment, Biomedical
"Technology Assessment, Biomedical" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Evaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems.
Descriptor ID |
D013673
|
MeSH Number(s) |
N03.880 N05.715.360.825
|
Concept/Terms |
Technology Assessment, Biomedical- Technology Assessment, Biomedical
- Biomedical Technology Assessment
- Technology Assessment, Health
- Assessment, Health Technology
- Assessments, Health Technology
- Health Technology Assessment
- Health Technology Assessments
- Technology Assessments, Health
- Assessment, Biomedical Technology
- Assessments, Biomedical Technology
- Biomedical Technology Assessments
- Technology Assessments, Biomedical
Technology Assessment- Technology Assessment
- Assessment, Technology
- Assessments, Technology
- Technology Assessments
|
Below are MeSH descriptors whose meaning is more general than "Technology Assessment, Biomedical".
Below are MeSH descriptors whose meaning is more specific than "Technology Assessment, Biomedical".
This graph shows the total number of publications written about "Technology Assessment, Biomedical" by people in this website by year, and whether "Technology Assessment, Biomedical" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 1 | 0 | 1 |
2002 | 1 | 1 | 2 |
2003 | 0 | 1 | 1 |
2004 | 1 | 1 | 2 |
2005 | 0 | 4 | 4 |
2007 | 0 | 5 | 5 |
2008 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2010 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2012 | 1 | 2 | 3 |
2014 | 0 | 1 | 1 |
2015 | 1 | 2 | 3 |
2017 | 1 | 0 | 1 |
2018 | 0 | 2 | 2 |
2019 | 4 | 0 | 4 |
2020 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Technology Assessment, Biomedical" by people in Profiles.
-
Brodie F, Repka M, Burns SA, Prakalapakorn SG, Morse C, Schuman JS, Duenas MR, Afshari N, Pollack JS, Thorne JE, Vitale A, Sen HN, Myung D, Blumenkranz MS, Tu E, Hammer DX, Tarver M, Cunningham B, Kagemann L, Sadda S, Sarraf D, Jaffe GJ, Eydelman M. Development, Validation, and Innovation in Ophthalmic Laser-Based Imaging: Report From a US Food and Drug Administration-Cosponsored Forum. JAMA Ophthalmol. 2021 01 01; 139(1):113-118.
-
Shen JF, Deng S, Hammersmith KM, Kuo AN, Li JY, Weikert MP, Shtein RM. Intraocular Lens Implantation in the Absence of Zonular Support: An Outcomes and Safety Update: A Report by the American Academy of Ophthalmology. Ophthalmology. 2020 09; 127(9):1234-1258.
-
Shtein RM, Shen JF, Kuo AN, Hammersmith KM, Li JY, Weikert MP. Autologous Serum-Based Eye Drops for Treatment of Ocular Surface Disease: A Report by the American Academy of Ophthalmology. Ophthalmology. 2020 01; 127(1):128-133.
-
Sobel RK, Aakalu VK, Wladis EJ, Bilyk JR, Yen MT, Mawn LA. A Comparison of Endonasal Dacryocystorhinostomy and External Dacryocystorhinostomy: A Report by the American Academy of Ophthalmology. Ophthalmology. 2019 11; 126(11):1580-1585.
-
Epstein D. Beyond the cost-effectiveness acceptability curve: The appropriateness of rank probabilities for presenting the results of economic evaluation in multiple technology appraisal. Health Econ. 2019 06; 28(6):801-807.
-
Epstein D, Esp?n J. Evaluation of new medicines in Spain and comparison with other European countries. Gac Sanit. 2020 Mar - Apr; 34(2):133-140.
-
Bakri SJ, Thorne JE, Ho AC, Ehlers JP, Schoenberger SD, Yeh S, Kim SJ. Safety and Efficacy of Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration: A Report by the American Academy of Ophthalmology. Ophthalmology. 2019 01; 126(1):55-63.
-
Patel R, Powell JT, Sweeting MJ, Epstein DM, Barrett JK, Greenhalgh RM. The UK EndoVascular Aneurysm Repair (EVAR) randomised controlled trials: long-term follow-up and cost-effectiveness analysis. Health Technol Assess. 2018 01; 22(5):1-132.
-
Rothery C, Claxton K, Palmer S, Epstein D, Tarricone R, Sculpher M. Characterising Uncertainty in the Assessment of Medical Devices and Determining Future Research Needs. Health Econ. 2017 02; 26 Suppl 1:109-123.
-
Wladis EJ, Bradley EA, Bilyk JR, Yen MT, Mawn LA. Oral Antibiotics for Meibomian Gland-Related Ocular Surface Disease: A Report by the American Academy of Ophthalmology. Ophthalmology. 2016 Mar; 123(3):492-6.